Today is Open Access Day1, intended to broaden awareness and understanding of Open Access. Many science bloggers have written about Open Access today,and links to a lot of these blog posts have been collected by Bora Zivkovic2 or are found in the FriendFeed room set up for the day3. The purchase of Biomed Central – the largest Open Access publisher – by Springer announced last week4, and the announcement of the Open Access Scholarly Publishers Association (OASPA) today5 are strong signs that Open Access has grown up and is no longer new and experimental. This is probably a good time to give a personal report on the role of Open Access in my own work, and obviously that perspective is very different from the perspective of a journal publisher or a patient advocate6. I wish that more of the discussion would be about practical benefits or disadvantages for the people involved, rather than using the sometimes “religious” arguments for or against Open Access.
This is a companion discussion topic for the original entry at https://front-matter.io/mfenner/open-access-whats-in-it-for-me